Furthermore, biotinylated deactivated Cas9 (dCas9) capture analysis combined with Immunoprecipitation and mass spectrometry analysis were performed to explore the mechanism by which MYBL1 transcriptionally activated ANGPT2 in HCC. The gene discussed is MYBL1; the disease is hepatocellular carcinoma.